Good COVID-19 Related Products – 3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Favipiravir Intermediate COVID-19 – Ruifu
Good COVID-19 Related Products – 3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Favipiravir Intermediate COVID-19 – Ruifu Detail:
Manufacturer with High Purity and Stable Quality
Commercial Supply Favipiravir (CAS: 259793-96-9) and Related Intermediates:
Favipiravir CAS: 259793-96-9
3,6-Dichloropyrazine-2-carbonitrile CAS: 356783-16-9
3,6-Difluoropyrazine-2-carbonitrile CAS: 356783-28-3
6-Bromo-3-hydroxypyrazine-2-carboxamide CAS: 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS: 55321-99-8
2-Aminopropanediamide CAS: 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS: 13433-00-6
Chemical Name | 3,6-Difluoropyrazine-2-Carbonitrile |
CAS Number | 356783-28-3 |
CAT Number | RF-PI227 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C5HF2N3 |
Molecular Weight | 141.08 |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | Pale Yellow to Off-White Powder |
Purity | ≥98.0% |
Loss on Drying | ≤1.0% |
Residue on ignition | ≤0.5% |
Test Standard | Enterprise Standard |
Usage | Pharmaceutical Intermediates; Favipiravir (CAS: 259793-96-9) Intermediate |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
3,6-Difluoropyrazine-2-Carbonitrile CAS: 356783-28-3 is an intermediate of Favipiravir (CAS: 259793-96-9).
Favipiravir (CAS: 259793-96-9) in the treatment of Influenza virus infections. Favipiravir, also known as Favilavir, T705, or Avigan, is a selective inhibitor of viral RNA-dependent RNA polymerase with activity against many RNA viruses, influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Activity against enteroviruses and Rift Valley fever virus has also been demonstrated. The mechanism of its actions is thought to be related to the selective inhibition of viral RNA-dependent RNA polymerase. Favipiravir does not inhibit RNA or DNA synthesis in mammalian cells and is not toxic to them. In 2014, favipiravir was approved in Japan for stockpiling against influenza pandemics.
Product detail pictures:
Related Product Guide:
With our loaded encounter and considerate services, we have now been recognized as a trustworthy supplier for lots of worldwide consumers for Good COVID-19 Related Products – 3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Favipiravir Intermediate COVID-19 – Ruifu , The product will supply to all over the world, such as: Turkey, Melbourne, Slovak Republic, We always adhere to follow the honesty, mutual benefit, common development, after years of development and the tireless efforts of all staff, now has perfect export system, diversified logistics solutions, thorough meet customer shipping, air transport, international express and logistics services. Elaborate one-stop sourcing platform for our customers!
By Sahid Ruvalcaba from Afghanistan - 2018.11.04 10:32
The customer service staff is very patient and has a positive and progressive attitude to our interest, so that we can have a comprehensive understanding of the product and finally we reached an agreement, thanks!
By Murray from Porto - 2018.12.05 13:53